| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 01/29/2009 | US20090031458 Thaumatin From Transgenic Barley |
| 01/29/2009 | US20090031457 Protection against herbivores |
| 01/29/2009 | US20090031455 Terpene hydroxylation |
| 01/29/2009 | US20090031454 Fatty Acid Hydroxylases and Uses Thereof |
| 01/29/2009 | US20090031453 Alanine 2, 3 aminomutases |
| 01/29/2009 | US20090031452 Vascular-preferred promoters |
| 01/29/2009 | US20090031451 Transgenic drought and freeze resistant plants; transfecting a plant cell with a gene expression vector comprising a polynucleotide that codes for G proteins, then generating transgenic plants having crops with enhanced resistance to enviromental stresses |
| 01/29/2009 | US20090031444 Homologous recombination in plants |
| 01/29/2009 | US20090031443 Constitutive Expression Cassettes For Regulation Of Plant Expression |
| 01/29/2009 | US20090031442 Methods for the production of plants resistant to HPPD herbicides |
| 01/29/2009 | US20090031441 Regulatory Genes for Plant Differentiation and Growth, and Use of the Same |
| 01/29/2009 | US20090031440 Expression Cassettes for Seed-Preferential Expression in Plants |
| 01/29/2009 | US20090030185 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins |
| 01/29/2009 | US20090030183 Interferon Beta-Like Molecules |
| 01/29/2009 | US20090030067 Anti-proliferative combination therapy comprising satraplatin or jm118 and a taxane |
| 01/29/2009 | US20090030055 PKC activation as a means for enhancing sAPPALPHA secretion and improving cognition using bryostatin type compounds |
| 01/29/2009 | US20090030027 Androgen Receptor Modulator Compounds and Methods |
| 01/29/2009 | US20090030023 Pyrimidine compounds and medicinal composition thereof |
| 01/29/2009 | US20090029972 Dibenzodiazepinone Analogues, Processes for Their Production and Their Use as Pharmaceuticals |
| 01/29/2009 | US20090029939 Pre-organized tricyclic integrase inhibitor compounds |
| 01/29/2009 | US20090029937 Biodegradable cationic polymer gene transfer compositions and methods of use |
| 01/29/2009 | US20090029929 Decoy Nucleic Acid to Synoviolin Gene Promoter |
| 01/29/2009 | US20090029916 Fibroblast Growth Factor-14 |
| 01/29/2009 | US20090029914 Albumin Fusion Proteins |
| 01/29/2009 | US20090029912 Method of enhancing proliferation and/or survival of mesenchymal precursor cells (mpc) |
| 01/29/2009 | US20090029909 Modulation of synaptogenesis |
| 01/29/2009 | US20090029861 dicamba monooxygenase (DMO) enzyme; producing dicamba tolerant plants, methods for controlling weed growth, and methods for producing food, feed, and other products |
| 01/29/2009 | US20090029860 Novel mutation involved in increased tolerance to imidazolinone herbicides in plants |
| 01/29/2009 | US20090029471 Microelectromechanical devices useful for manipulating cells or embryos, kits thereof, methods of making same, and methods of use thereof |
| 01/29/2009 | US20090029470 Process and culturing unit for culturing biological cells |
| 01/29/2009 | US20090029469 Method for in vitro proliferation of dendritic cell precursors and their use to produce immunogens |
| 01/29/2009 | US20090029468 Zinc finger binding domains for cnn |
| 01/29/2009 | US20090029467 contacting targeted therapeutic with a cell deficient in a lysosomal enzyme, wherein the cell expresses the cation-independent mannose-6-phosphate receptor on the surface, thereby targeting the therapeutic enzyme to the lysosome; insulin-like growth factor 2 receptor |
| 01/29/2009 | US20090029465 Culturing Human Embryonic Stem Cells |
| 01/29/2009 | US20090029464 Feeder Independent Extended Culture of Embryonic Stem Cells |
| 01/29/2009 | US20090029463 Differentiation of Multi-Lineage Progenitor Cells to Chondrocytes |
| 01/29/2009 | US20090029462 Automated method and apparatus for embryonic stem cell culture |
| 01/29/2009 | US20090029461 Immortalised Feeder Cells |
| 01/29/2009 | US20090029460 Neoplasm-specific polypeptides and their uses |
| 01/29/2009 | US20090029459 Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions |
| 01/29/2009 | US20090029458 Chicken leukemia inhibitory factor (LIF) and gene thereof |
| 01/29/2009 | US20090029457 Pharmaceutical composition for inducing an immune response in a human or animal |
| 01/29/2009 | US20090029456 STR50 and uses thereof |
| 01/29/2009 | US20090029455 Chimeric t1r1 taste receptor encoding nucleic acid sequences and vectors |
| 01/29/2009 | US20090029449 Method and apparatus for substantially isolating plant tissues |
| 01/29/2009 | US20090029444 Novel recombinant anticoagulant proteins |
| 01/29/2009 | US20090029439 Regeneration |
| 01/29/2009 | US20090029438 Composite materials comprising supported porous gels |
| 01/29/2009 | US20090029419 Expression of modified antibodies in avian cells |
| 01/29/2009 | US20090029415 Peripheral nervous system specific sodium channels, DNA encoding therefor, crystallization, X-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof |
| 01/29/2009 | US20090029370 Real time nucleic acid detection in vivo using protein complementation |
| 01/29/2009 | US20090029368 Method for determining the cell culture history of a cell unit labelled with more than one type of tag |
| 01/29/2009 | US20090029366 Methods of identifying modulators of hyperpolarization-activated cyclic nucleotide-gated (hcn) channels |
| 01/29/2009 | US20090029365 Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of colon cancer |
| 01/29/2009 | US20090029361 Growth differentiation factor-7 |
| 01/29/2009 | US20090029351 Method of measuring human cyp3a inducibility |
| 01/29/2009 | US20090029345 Modulating skeletal muscle |
| 01/29/2009 | US20090029341 Sample Support and Sample Store, Especially For the Cryopreservation of Biological Samples |
| 01/29/2009 | US20090029340 Cryoprotective Compositions and Methods of Using Same |
| 01/29/2009 | US20090029322 Use of Stem Cells, Method of Tissue Engineering, Use of Dental Tissues and Tooth Biological Substitute |
| 01/29/2009 | US20090029004 Phytase variants |
| 01/29/2009 | US20090028919 Systems and methods of promoting engraftment of a hybrid lower limb artery bypass vascular graft in a mammal |
| 01/29/2009 | US20090028901 use of such proteins in isolating various types of attenuated viruses for the development of vaccine and pharmaceutical formulations; protocols utilizing interferon antagonists, e.g., NS1, to enhance gene therapy or DNA vaccination based on their ability to increase gene expression |
| 01/29/2009 | US20090028893 Methods for producing fusion polypeptides or enhancing expression of fusion polypeptides |
| 01/29/2009 | US20090028892 Ostertagia Vaccine |
| 01/29/2009 | US20090028889 Novel Polypeptide Ligands For Toll-Like Receptor 2 (TLR2) |
| 01/29/2009 | US20090028888 Cancer Antigen Mage-A9 and Uses Thereof |
| 01/29/2009 | US20090028887 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 01/29/2009 | US20090028884 Oligomeric receptor ligand pair member complexes |
| 01/29/2009 | US20090028883 Novel P-selectin Ligand Protein |
| 01/29/2009 | US20090028882 Methods of inhibiting binding of beta-sheet fibril to rage and consequences thereof |
| 01/29/2009 | US20090028880 Serum albumin binding proteins |
| 01/29/2009 | US20090028877 Antibody Composition Specifically Binding to Ganglioside Gm |
| 01/29/2009 | US20090028876 Methods of modifying cd11c+ dendritic cell development to form osteoclasts functional in the bone environment |
| 01/29/2009 | US20090028875 Use of gilz protein expressed in dendritic cells to modulate an antigen-specific immune response |
| 01/29/2009 | US20090028872 Human monoclonal antibodies to cd70 |
| 01/29/2009 | US20090028870 Treatment of Hematologic Disorders |
| 01/29/2009 | US20090028863 Markers for diagnosis of cancer and its use |
| 01/29/2009 | US20090028859 Bispecific antibodies that bind to vegf receptors |
| 01/29/2009 | US20090028856 Anti-CD79B Antibodies and Immunoconjugates and Methods of Use |
| 01/29/2009 | US20090028855 Inhibitors of akt/pkb with anti-tumor activity |
| 01/29/2009 | US20090028851 Novel Antibodies Directed to the Mammalian Eag1 Ion Channel Protein |
| 01/29/2009 | US20090028844 Galnts as modifiers of the igfr pathway and methods of use |
| 01/29/2009 | US20090028842 Dekkera/Brettanomyces Cytosine Deaminases And Their Use |
| 01/29/2009 | US20090028838 Hematopoietic cell culture nutrient supplement |
| 01/29/2009 | US20090028837 Methods for Altering the Reactivity of Plant Cell Walls |
| 01/29/2009 | US20090028836 Stem and progenitor cell expansion by evi, evi-like genes and setbp1 |
| 01/29/2009 | US20090028835 Human transcriptome corresponding to human oocytes and use of said genes or the corresponding polypeptides to trans-differentiate somatic cells |
| 01/29/2009 | US20090028834 Methods and compositions for stimulating the proliferation or differentiation of stem cells with substance P or an analog thereof |
| 01/29/2009 | US20090028833 Proliferative Primary Human Sertoli Cell Cultures And Their Applications |
| 01/29/2009 | US20090028831 Stem cell regulator, compositions and methods of use |
| 01/29/2009 | US20090028830 Preparation of multipotent stem cells and the use thereof |
| 01/29/2009 | US20090028825 Compositions and Methods for Studying and Treating Inflammatory Diseases and Disorders |
| 01/29/2009 | US20090028813 Methods for Treating Body Tissue |
| 01/29/2009 | US20090028795 NOD1 as an Anti-Tumor Agent |
| 01/29/2009 | US20090028793 Vascular Tumor Markers |
| 01/29/2009 | US20090028784 Antibodies to IL-6 and use thereof |
| 01/29/2009 | DE102007035659A1 Immortalisierte Keratinozyten-Zelllinie und Verfahren zur Messung von protektiven Mitteln An immortalized keratinocyte cell line and method for measuring protective agents |
| 01/29/2009 | DE102007034679A1 Materialzusammensetzungen, welche aus exokrinem Drüsengewebe erhaltene adulte Stammzellen enthalten, insbesondere zur Verwendung in der Regenerationsmedizin, zB zur Wiederherstellung von verletztem oder geschädigtem Myokardgewebe Material compositions containing obtained from exocrine glandular tissue of adult stem cells, particularly for use in regenerative medicine, for example, to restore injured or damaged myocardial tissue |
| 01/29/2009 | CA2720628A1 Fusion proteins |